How a pharmacist-led primary care clinic can improve respiratory care Nazir Hussain, a specialist respiratory pharmacist at Dudley Integrated Health and Care NHS Trust, shares how he is improving respiratory care by offering GP-based clinics to help patients manage their COPD and asthma.…
Improving asthma care for children and young people Considerations for pharmacists in helping young patients manage their asthma.…
‘Blanket switch’ to greener inhalers not recommended in prescribing guidance The Scottish government has published a consultation on draft guidance emphasising that patients should only be switched to greener inhalers “if effectiveness, safety or adherence is not compromised”.…
Children and young people with asthma: symptoms, diagnosis and the role of pharmacy The first of our two-part series on asthma in children and young people is an overview of the condition, outlining the role pharmacy can play in supporting patients and their families and/or carers.…
Medicines regulator approves UK’s first dual combination inhaler for mild asthma AstraZeneca said the marketing authorisation meant its Symbicort Turbohaler 200/6 could be used by 2.7 million adults in the UK who live with mild asthma.…
Some patients switched to ‘greener’ inhalers without consultation, say experts Exclusive: Experts warn that non-consented inhaler switches pose risks to patients' health and advise physicians to carry out individual inhaler checks to avoid this.…
NHS develops dashboard to identify possible over-prescribing of prednisolone The dashboard calculates the total cumulative dose of prednisolone prescribed to patients in England in the past 12 months, allowing those at risk to be considered for alternative treatment methods.…
Half of asthma patients in the UK overusing SABAs, study finds In a UK asthma programme, 284,683 out of 574,913 patients were found to be “potentially overusing” short-acting β2-agonists.…
Personalised medicine approach could benefit people with asthma Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.…
Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research finds A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.…
